Studies

Sign up for our FREE Weekly Newsletter
Current Issue Past Issue

News and Information for Medical Professionals

Search Diabetes In Control

Studies Articles
Ordered by most recent

Article Title	Brief Description
A Decade Later, Lifestyle Changes or Metformin Still Lower Type 2 Diabetes Risk	Study reports on persistence of benefits seen in the Diabetes Prevention Program
Clinical Research Reviews	Four clinical trials of Neuragen® have been completed to date with 180 patients.
WarmFeet Relaxation Study	Birgitta I. Rice, MS, R.Ph., CHES, the developer of the WarmFeet Therapy, has asked us to invite you to participate in an educator, patient feedback study.
10,000 Step Study	With the help from Omron Healthcare, we enrolled educators who each signed up patients with diabetes to complete a 3-month study. The study consisted of each patient receiving a pedometer to monitor their steps and a commitment that they would make 10,000 steps a day. By using a pedometer to motivate patients, we hoped to show a reduction in A1c's and lipids, thereby reducing the risk for complications for those with Diabetes.
THE TRIGR TRIAL	THE TRIGR TRIAL will determine whether delayed exposure to intact food proteins will reduce the chances of developing type 1 diabetes later in life. If you have a patient who is pregnant that has type 1 diabetes or the unborn child's father has type 1 diabetes or the unborn child has a full sibling with type 1 diabetes, then click here to learn more http://www.trigrnorthamerica.org/index.html
CLOSED!!!!! CLOSED!!!! FIRST STEP PROGRAM GRANT – Need 50 Medical Professiona	We are looking for medical professionals to participate with us in a research grant to provide The First Step Program to 1000 patients. The first step program is a lifestyle physical activity intervention designed to increase physical activity. It will be for patients with type 2 diabetes or prediabetes.
Insulin Travel Adjustment Guide	Insulin Travel Adjustment GuideTABLE 2: Insulin Adjustment Traveling EAST Across Multiple Time Zones
The ABC's + of Diabetes	The ABC's + of Diabetes A is for A1C: This is the test that measures your average blood glucose over the past 3 months. ADA suggested target: below 7. How often should you have your A1C tested? At least twice a year
Tolerx Phase 3 Study	DEFEND is a Phase 3 clinical study of otelixizumab in YOUNG ADULTS with newly diagnosed T1DM. Otelixizumab is an investigational agent, not yet approved by the FDA for marketing. DEFEND will determine if otelixizumab can help preserve the ability to make endogenous insulin and stop the destruction of the body's cells that make insulin (beta cells). You can find out more at: www.defendagainstdiabetes.com

Navigate through our listing of Studies articles here.

9 Total articles for Studies

Looking for a particular Newsletter Issue? Click Here

Go way back.
See the DIC Archives

Diabetes In Control Advertisers

Print This Week's Newsletter
Download This Week's Newsletter
Newsletter is in Adobe format
If you don't haveAdobe Acrobat Reader , you can download it for Free here .

Free CE Available
CE Programs On Diabetes Available here

Text Advertisement

Search Articles On Diabetes In Control

Sign up for our FREE Weekly Newsletter
Current Issue Past Issue

Privacy / Advertising With Us / Contact Us

Entries (RSS News)

Add us to your favorite news reader

DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.